Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use

Melissa Crawford(GlaxoSmithKline (United Kingdom)), Nassrin Payvandi(ViiV Healthcare (United Kingdom)), Annemiek de Ruiter(ViiV Healthcare (Spain)), Brian Wynne(Research Triangle Park Foundation), Beth Romach(Triangle), Michael Aboud(ViiV Healthcare (United Kingdom)), Vani Vannappagari, Kimberly Y. Smith(UCLA Medical Center), Lloyd Curtis, Jean van Wyk(ViiV Healthcare (United Kingdom))
JAIDS Journal of Acquired Immune Deficiency Syndromes
October 18, 2019
10.1097/qai.0000000000002213
Cited by 12

Related Papers

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006
|AIDS|2008|582
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
|AIDS|2002|359
A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population
|Infectious Diseases and Therapy|2018|197